Loading clinical trials...
Loading clinical trials...
To Compare the Immunogenicity & Safety of GSK Biologicals New Adjuvanted Hepatitis B Vaccine to a Double Dose of Engerix™-B, in Pre-Haemodialysis/Haemodialysis Patients (≥15 Years of Age)
Conditions
Interventions
Hepatitis B adjuvanted vaccine
Engerix-B
Locations
3
Czechia
GSK Clinical Trials Call Center
Hradec, Králové, Czechia
GSK Clinical Trials Call Center
Kuala Lumpur, Malaysia
GSK Clinical Trials Call Center
Málaga, Spain
Start Date
December 1, 1999
Last Updated
October 3, 2006
NCT07024641
NCT06671093
NCT07275554
NCT03826433
NCT06885710
NCT06947499
Lead Sponsor
GlaxoSmithKline
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions